Skip to main content

Herena Eixarch Ahufinger

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Herena Eixarch Ahufinger

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Red Española de Esclerosis Múltiple

IP: Xavier Montalban Gairín
Collaborators: Susana Otero Romero, Carlos Nos Llopis, Sunny Malhotra Sareen, Jaume Sastre Garriga, Jordi Rio Izquierdo, Fco. Javier Aymerich Martínez, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Carmen Tur Gomez, Cristina Auger Acosta, Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Alex Rovira Cañellas, Mar Tintore Subirana, M Jesus Arevalo Navines, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo
Funding agency: Instituto de Salud Carlos III
Funding: 198090
Reference: RD12/0032/0017
Duration: 01/01/2013 - 31/12/2016

Función de las semaforinas 3A y 7A, moléculas de guía axonal, en la neurorregeneración y la regulación de la respuesta inmunitaria en la encefalomielitis autoinmune experimental

IP: Carmen Espejo Ruiz
Collaborators: Herena Eixarch Ahufinger, Mireia Castillo Juarez
Funding agency: Instituto de Salud Carlos III
Funding: 173030
Reference: PI09/01180
Duration: 01/01/2010 - 30/06/2014

Nuevas estrategias basadas en las células mieloides supresoras expresando autoantígenos para inducir tolerancia. Aplicación en un modelo experimental de esclerosis múltiple

IP: Jordi Barquinero Mañez
Collaborators: Herena Eixarch Ahufinger
Funding agency: Instituto de Salud Carlos III
Funding: 134915
Reference: PI09/00237
Duration: 01/01/2010 - 31/12/2013

Unitat de Neuroimmunologia Clínica (UNiC) - Centre d'Esclerosi Múltiple de Catalunya (CEM-Cat)

IP: Xavier Montalban Gairín
Collaborators: Herena Eixarch Ahufinger, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 144000
Reference: CD09/00363
Duration: 08/01/2010 - 19/08/2014

Related news

The Barcelona Risk Score is a flexible, generalisable clinical tool that will play a key role in selecting the most effective treatment for each person with multiple sclerosis

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.

Related professionals

David Berlana Martín

David Berlana Martín

Research technician
Basic, Translational and Clinical Pharmacy Research
Read more
Laia Pinos  Tella

Laia Pinos Tella

Epidemiology and Public Health
Read more
Manuel Armengol Carrasco

Manuel Armengol Carrasco

Head of group
General Surgery
Read more
M Jesus Arevalo  Navines

M Jesus Arevalo Navines

Postdoctoral researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.